Clinical Trials Sponsored by Naurex, Inc

Total 35544 results

Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Poland, Hungary, Japan, Slovakia
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Rapastinel as Monotherapy in Patients With MDD

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Terminated

A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Assessment of Effect of Rapastinel on Driving Performance

Driving Performance

United States, Canada
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers (NRX-1074)

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Slovakia, Poland, Hungary, Japan, Russian Federation
Naurex, Inc, an affiliate of Allergan plc

Completed

Assessment of Abuse Potential of Rapastinel in Humans

Human Abuse Potential

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Safety and Pharmacokinetics of NRX-1074 in Normal Volunteers

Healthy

United States
Naurex, Inc, an affiliate of Allergan plc

Terminated

Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Terminated

Open Label Extension for GLYX13-C-202, NCT01684163

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Depressive Disorder, Major

United States
Naurex, Inc, an affiliate of Allergan plc

Withdrawn

Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)

Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc

Completed

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Major Depressive Disorder

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Single Ascending Dose Safety, Tolerability and Pharmacokinetics Study of GLYX-13 in Normal Volunteers

Healthy

United States
Naurex, Inc, an affiliate of Allergan plc

Completed

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Major Depressive Disorder

United States
Anulex Technologies, Inc.

Completed

Randomized Study of Anular Repair With the Xclose Tissue Repair System

Diskectomy

United States
Naturex-Dbs

Unknown

Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS)

Lower Urinary Tract Symptoms
Nurix Therapeutics, Inc.

Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Primary Central Nervous System Lymphoma (PCNSL) | Marginal Zone Lymphoma (MZL) | Waldenstrom Macroglobulinemia (WM) | Diffuse Large B Cell Lymphoma (DLBCL)

United States, United Kingdom, Netherlands
Nurix Therapeutics, Inc.

Active, not recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Primary Central Nervous System Lymphoma (PCNSL) | Marginal Zone Lymphoma (MZL) | Waldenstrom Macroglobulinemia (WM)

United States
Zurex Pharma, Inc.

Completed

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP) (ZP)

Surgical Skin Preparation

United States
Zurex Pharma, Inc.

Completed

In-vivo Efficacy of Patient Preoperative Prep

Surgical Skin Preparation

United States
Nurix Therapeutics, Inc.

Active, not recruiting

A Study of DeTIL-0255 in Adults With Advanced Malignancies

Cervical Cancer | Endometrial Cancer | Platinum-resistant Ovarian Cancer

United States
Zurex Pharma, Inc.

Completed

Clinical Evaluation of Patient Preoperative Prep

Surgical Skin Preparation

United States
Zurex Pharma, Inc.

Completed

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Surgical Site Infection

United States
Nurix Therapeutics, Inc.

Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

Cervical Cancer | Gastric Cancer | Head and Neck Squamous Cell Carcinoma | Non-small Cell Lung Cancer (NSCLC) | Metastatic Urothelial Carcinoma | Ovarian Cancer, Epithelial | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Triple Negative Breast Cancer (TNBC) | Malignant Pleural Mesothelioma... and other conditions

United States, United Kingdom
Zurex Pharma, Inc.

Completed

Perioperative Patient Skin Antiseptic Preparation Evaluation

Surgical Site Infection

United States
Zurex Pharma, Inc.

Completed

Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle

Surgical Site Infection

United States
Zurex Pharma, Inc.

Terminated

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0035)

Surgical Site Infection

United States
Zurex Pharma, Inc.

Completed

Efficacy Study to Evaluate Antimicrobial Effectiveness of ZuraPrep™ (ZX-ZP-0055)

Surgical Site Infection

United States
Zurex Pharma, Inc.

Completed

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

Surgical Site Infection

United States
Naturex SA
BioFortis

Completed

A Clinical Trial to Evaluate the Chronic Safety and Tolerance of Turmipure Gold™ in Healthy Subjects (TURBIO-GOLD)

Liver Function | Gastrointestinal Tolerance | Kidney Function

France
Laval University
Naturex

Completed

Effects of Cranberry Powder Supplements on Gut Microbiota Diversity and Metabolic Syndrome (MICA)

Overweight | Metabolic Syndrome | Insulin Resistance | Endotoxemia | Microbiota

Canada
Northumbria University
Naturex

Completed

To Assess the Influence of Aronox on Parameters Associated With Aerobic Performance

Aerobic Capacity

United Kingdom
University of Reading
Naurex, Inc, an affiliate of Allergan plc

Completed

An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults

Cognitive Decline

United Kingdom
NYU Langone Health
Naurex, Inc, an affiliate of Allergan plc

Withdrawn

NRX-1074 in Early Course Schizophrenia

Schizophrenia

United States
NuRx Pharmaceuticals, Inc.

Unknown

Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

United States
NuRx Pharmaceuticals, Inc.

Unknown

Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia

United States
Northumbria University
Naturex SA

Completed

To Assess the Influence of Aronox on Parameters Associated With Recovery Following Muscle Damaging Exercise

Muscle Damage

United Kingdom
University of Reading
Naturex

Recruiting

Enhancement of Calmness and Mood Following Acute Lemon Balm Supplementation During Cognitive Demand in Adults (LemCog)

Stress | Mood Disturbance

United Kingdom
University of Reading
Naturex

Completed

Enhancement of Sleep Quality and Mood Following Supplementation With Lemon Balm in an Adult Population (Lemslp)

Sleep Disturbance | Mood Disturbance

United Kingdom
University of Reading
Naturex

Completed

Investigating the Acute and Chronic Effects of an American Ginseng Root Extract on Cognition and Mood

Cognitive Change | Effects of Ginseng on Cognitive Function

United Kingdom
Assisting Nature

Unknown

A New Revolutionary 3-Injection- Protocol in Infertile Women

Infertility, Female

Greece
Assisting Nature

Recruiting

Invasive PGT-A Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Infertility | Aneuploidy | Chromosome Abnormality

Greece
Assisting Nature

Recruiting

Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Infertility | Aneuploidy | Chromosome Abnormality

Greece
Assisting Nature

Unknown

Single Follicular Dexarelix for LH Suppression During Ovarian Stimulation in Oocyte Donors.

Infertility | Premature Ovarian Failure

Greece

Clinical Trials Sponsored by Naurex, Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations